Skip to main content

Table 1 Baseline characteristics with age, gender, histology including tumor differentiation and Child-Pugh score.

From: Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

Patient Age Gender Histologya Histological differentiationb Child-Pugh
1 58 male HCC + A
2 59 male HCC + A
3 65 male HCC - B
4 72 male HCC ++ A
5 65 male HCC ++ A
6 65 male HCC/CC +/- -c
7 67 male HCC + B
8 63 female HCC ++ A
9 71 male HCC ++ A
10 65 male HCC ++ A
11 43 male HCC ++ A
12 77 male HCC + A
13 54 male HCC + A
14 65 male HCC ++ A
15 66 male HCC + A
16 65 male HCC - A
17 61 male HCC + A
18 76 male HCC - A
19 59 male HCC - B
20 65 male HCC n.d.d A
21 69 male HCC + A
  1. aHCC/CC means a tumor with characteristics of both, hepatic and biliary differentiation.
  2. bHistological differentiation: (++) good, (+) moderate and (-) poor tumor differentiation type.
  3. cNo cirrhosis according to the histology of the liver.
  4. dNo histology available; however, AFP value 1.591 μg/l and typical noninvasive HCC criteria
  5. according to current imaging guidelines.